AYURCANN Q1 2026 Posts CA$14.64M in Gross Sales

Ayurcann Holdings Corp. (“Ayurcann”) has announced its results for the quarter ended September 30, 2025 — Q1 2026 — reporting gross revenue of CA$ 14,638,697. Gross profit reached CA$ 2,236,343, yielding a gross margin of 26%, compared with a 40% margin a year earlier. Despite a slight dip in margin, the company attributed the results to “robust demand across expanding product categories” and strong national distribution efforts. Ayurcann now ranks as a Top‑3 vape producer by volume in Ontario, holding roughly 7% of the Ontario vape market and 5% of Canada’s national vape market — underscoring its growing presence in one of the country’s fastest‑growing segments. Over the past six months the firm has introduced 30 new stock‑keeping units (SKUs) across vapes, pre‑rolls, and concentrates, expanding its shelf presence and retail adoption nationwide. Looking ahead, Ayurcann plans to scale up further into high‑demand pre‑rolls and concentrates, aiming to cement its role as a trusted national supplier for both retailers and consumers across licensed Canadian stores. #Ayurcann #CannabisIndustry #Q12026Results #VapeMarket #SlimScan #GrowthStocks #CANSLIM